The Business of Testing-dtet
Genetics Update: 23andMe Seeks to Upend the Medical Industry via Genetic Testing Information Sharing
Upfront Next-Generation Sequencing for Lung Cancer Patients Saves Time, Money
From - Diagnostic Testing & Emerging Technologies
Use of upfront next-generation sequencing (NGS) testing at diagnosis of patients with metastatic non-small-cell lung cancer (mNSCLC) is…
Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy
From - Diagnostic Testing & Emerging Technologies
Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to…